Literature DB >> 23794250

Further delineation of genotype-phenotype correlation in homozygous 2p21 deletion syndromes: first description of patients without cystinuria.

Deborah Bartholdi1, Reza Asadollahi, Beatrice Oneda, Thomas Schmitt-Mechelke, Paolo Tonella, Alessandra Baumer, Anita Rauch.   

Abstract

Homozygous contiguous gene deletion syndromes are rare. On 2p21, however, several overlapping homozygous gene deletion syndromes have been described, all presenting with cystinuria but otherwise distinct phenotypes. Hypotonia-cystinuria syndrome (HCS, OMIM606407) is characterized by infantile hypotonia, poor feeding, and growth hormone deficiency. Affected individuals carry homozygous deletions including the cystinuria gene SLC3A1 and the adjacent PREPL gene. Larger homozygous deletions in this region encompassing the PPM1B, SLC3A1, PREPL, and C2orf34 (CAMKMT) genes result in a more severe phenotype, the 2p21 deletion syndrome. A phenotype intermediate to HCS and the 2p21 deletion syndrome is termed atypical HCS and is caused by deletion of SLC3A1, PREPL, and C2orf34 (CAMKMT). Using high resolution SNP array molecular karyotyping we identified two siblings with a homozygous deletion of 83 kb partially encompassing the genes PREPL and C2orf34 (CAMKMT), but not the SLC3A1 gene. The affected siblings display a recognizable phenotype which is similar to atypical HCS with regard to growth failure and neuro-muscular features, but is characterized by lack of cystinuria. The patients also exhibit features which have not been reported to date such as cleft palate and genital abnormalities. In conclusion, we report the first patients with a homozygous 2p21 deletion syndrome without cystinuria and further delineate the complex genotype-phenotype correlations of homozygous microdeletion syndromes of this region.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  deletion 2p21; homozygous gene deletion syndrome; hypotonia-cystinuria syndrome; neonatal hypotonia

Mesh:

Substances:

Year:  2013        PMID: 23794250     DOI: 10.1002/ajmg.a.35994

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  11 in total

1.  First cardiac manifestation of hypotonia-cystinuria syndrome.

Authors:  Mustafa Kılıç; Ahmet Cevdet Ceylan; Utku Arman Örün; Esra Kılıç
Journal:  Metab Brain Dis       Date:  2018-04-07       Impact factor: 3.584

2.  PREPL deficiency with or without cystinuria causes a novel myasthenic syndrome.

Authors:  Luc Régal; Xin-Ming Shen; Duygu Selcen; Chantal Verhille; Sandra Meulemans; John W M Creemers; Andrew G Engel
Journal:  Neurology       Date:  2014-03-07       Impact factor: 9.910

Review 3.  The second point mutation in PREPL: a case report and literature review.

Authors:  Sebastian Silva; Noriko Miyake; Carolina Tapia; Naomichi Matsumoto
Journal:  J Hum Genet       Date:  2018-02-26       Impact factor: 3.172

4.  Developmental constraint through negative pleiotropy in the zygomatic arch.

Authors:  Christopher J Percival; Rebecca Green; Charles C Roseman; Daniel M Gatti; Judith L Morgan; Stephen A Murray; Leah Rae Donahue; Jessica M Mayeux; K Michael Pollard; Kunjie Hua; Daniel Pomp; Ralph Marcucio; Benedikt Hallgrímsson
Journal:  Evodevo       Date:  2018-01-27       Impact factor: 2.250

5.  First maternal uniparental disomy for chromosome 2 with PREPL novel frameshift mutation of congenital myasthenic syndrome 22 in an infant.

Authors:  Ping Zhang; Bingbing Wu; Yulan Lu; Qi Ni; Renchao Liu; Wenhao Zhou; Huijun Wang
Journal:  Mol Genet Genomic Med       Date:  2020-01-27       Impact factor: 2.183

6.  Novel deletion alleles of a C. elegans gene Y48E1C.1, named as tm5468, tm5625 and tm5626.

Authors:  Sayaka Hori; Yuji Suehiro; Sawako Yoshina; Shohei Mitani
Journal:  MicroPubl Biol       Date:  2017-10-03

7.  Prolyl endopeptidase-like is a (thio)esterase involved in mitochondrial respiratory chain function.

Authors:  Karen Rosier; Molly T McDevitt; Joél Smet; Brendan J Floyd; Maxime Verschoore; Maria J Marcaida; Craig A Bingman; Irma Lemmens; Matteo Dal Peraro; Jan Tavernier; Benjamin F Cravatt; Natalia V Gounko; Katlijn Vints; Yenthe Monnens; Kritika Bhalla; Laetitia Aerts; Edrees H Rashan; Arnaud V Vanlander; Rudy Van Coster; Luc Régal; David J Pagliarini; John W M Creemers
Journal:  iScience       Date:  2021-11-14

8.  PREPL deficiency: delineation of the phenotype and development of a functional blood assay.

Authors:  Luc Régal; Emma Mårtensson; Isabelle Maystadt; Nicol Voermans; Damien Lederer; Alberto Burlina; María Jesús Juan Fita; A Jeannette M Hoogeboom; Mia Olsson Engman; Tess Hollemans; Meyke Schouten; Sandra Meulemans; Tord Jonson; Inge François; David Gil Ortega; Erik-Jan Kamsteeg; John W M Creemers
Journal:  Genet Med       Date:  2017-07-20       Impact factor: 8.822

9.  Calmodulin Methyltransferase Is Required for Growth, Muscle Strength, Somatosensory Development and Brain Function.

Authors:  Sitvanit Haziza; Roberta Magnani; Dima Lan; Omer Keinan; Ann Saada; Eli Hershkovitz; Nurit Yanay; Yoram Cohen; Yoram Nevo; Robert L Houtz; Val C Sheffield; Hava Golan; Ruti Parvari
Journal:  PLoS Genet       Date:  2015-08-06       Impact factor: 5.917

10.  The clinical significance of small copy number variants in neurodevelopmental disorders.

Authors:  Reza Asadollahi; Beatrice Oneda; Pascal Joset; Silvia Azzarello-Burri; Deborah Bartholdi; Katharina Steindl; Marie Vincent; Joana Cobilanschi; Heinrich Sticht; Rosa Baldinger; Regina Reissmann; Irene Sudholt; Christian T Thiel; Arif B Ekici; André Reis; Emilia K Bijlsma; Joris Andrieux; Anne Dieux; David FitzPatrick; Susanne Ritter; Alessandra Baumer; Beatrice Latal; Barbara Plecko; Oskar G Jenni; Anita Rauch
Journal:  J Med Genet       Date:  2014-08-08       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.